This Diabetes Drug May Lower Bone Fracture Risk
16 June 2026 at 11:30
Semaglutide has become one of the most talked-about medicines in recent years because of its ability to help people with type 2 diabetes and obesity lose weight. Doctors have welcomed its benefits for blood sugar control and weight management, but questions remain about how significant weight loss affects other parts of the body, especially bones. [β¦]
The post This Diabetes Drug May Lower Bone Fracture Risk appeared first on Knowridge Science Report.